Keys to effective clinical trial monitoring
Clinical trial monitoring is essential for maintaining the quality and integrity of data. In this article, we delve into the keys to effective monitoring and explore how decentralized trials can benefit pharmaceutical and biotechnology companies
Celebrating 25 years of innovation in biotechnology: Sermes CRO at the presentation of the Asebio 2023 report
We attended the presentation of the Asebio 2023 Report, an essential event for the Spanish biotechnology sector. This year is particularly special as Asebio celebrates its 25th anniversary, and at Sermes CRO, we are proud to be part of this ecosystem, having been in the industry for 27 years. The advancements and achievements in this sector are impressive, with collaboration being a crucial pillar
European Artificial Intelligence Regulation: Missed Opportunity or Protective Shield
One sector significantly impacted by the use and development of Artificial Intelligence is healthcare and by extension Clinical Research The new Regulation is crucial for AI development as it affects not only technological advancement but also our fundamental rights
Azur Global Nutrition relies on Sermes CRO’s technological solutions
Azur Global Nutrition, leader in specialized solutions focused on immunonutrition, had many biological samples and clinical information coming from its research and development projects. They needed to organize and manage it in a systematic way. Sermes CRO then designed and created a personalized web portal that integrates application at user level and database. This solution allowed Azur Global Nutrition to work more efficiently, always measure their results and control the main process indicators
Specialist Unit Big Data & B.Intelligence in health develops the new Sermes CRO Covid-19 Dashboard
Sermes CRO ‘Big Data & BI Department’ has just developed the Sermes CRO Covid-19 Dashboard that provides updated info about reported Coronavirus cases
Sermes CRO awarded as the most Innovative company global supplier 2019 by MSD company (Merck Sharp and Dhome)
Sermes CRO Team, led by their CEO and founder Antonio Berlanga, accompanied by the responsible for clinical research and resposible of business development, has been awarded as the most company as the most Innovative company global supplier 2019 by MSD company (Merck Sharp and Dhome).
“Sermes CRO is committed to investing in the development of specific and technological areas”
From Sermes CRO years ago, we saw how this process came to stay and we bet on it. We invest in teams of specialized people to be able to create our own solutions and manage the information in an autonomous way. Nowadays, we have the necessary tools to give all kinds of services from our CRO/E-cro of high quality, budgetary efficiency and in the shortest time.